Novartis Pharmaceuticals Business Systems Analyst Salaries in Boston
The average Novartis Pharmaceuticals Business Systems Analyst in Boston earns an estimated $96,709 annually, which includes an estimated base salary of $87,587 with a $9,122 bonus. Novartis Pharmaceuticals' Business Systems Analyst compensation is $13,238 more than the US average for a Business Systems Analyst. Business Systems Analyst salaries at Novartis Pharmaceuticals in Boston can range from $46,500 - $215,000.
In Boston, The Operations Department at Novartis Pharmaceuticals earns $5,565 more on average than the Finance Department.
Last updated 2 years ago.
- $87,587
- avg. base
- $9,122
- avg. bonus
Business Systems Analyst Salaries at Novartis Pharmaceuticals
In Boston, Business Systems Analysts earn $2,462 more than Business Analysts, and $4,325 less than Operations Managers.
Compensation at Novartis Pharmaceuticals by Department
In Boston, The Operations Department averages $5,565 more than the Finance Department, and $22,149 less than the Marketing Department
Business Systems Analyst Compensation by Gender (All Companies)
The average female Business Systems Analyst at companies similar size to Novartis Pharmaceuticals reported making $89,933, while the average male Business Systems Analyst at similar sized companies reported making $93,781.
Business Systems Analyst Compensation by Ethnicity (All Companies)
The average Native American Business Systems Analyst at companies similar size to Novartis Pharmaceuticals reported making $115,000, while the average African American/Black Business Systems Analyst at similar sized companies reported making $75,705.
How Business Systems Analysts at Novartis Pharmaceuticals Rate Their Compensation
The majority of Business Systems Analysts at Novartis Pharmaceuticals believe they're compensated fairly. 100% of Business Systems Analysts at Novartis Pharmaceuticals say they receive annual bonuses, and the vast majority (79%) are satisfied with their benefits. See more compensation ratings at Novartis Pharmaceuticals
